ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 01/17/2020
Closing price: 285.50
Support price level: $270.83
Resistance price level: $302.25
Relative strength index (14-day RSI) 31.3
Beta 1.14
  • With a -15.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • BIIB is one of this month's worst performers with a return of -3.7%, underperforming 90 percent of stocks in the S&P-100.

  • Down 3.7 percent, BIIB is one of this week's biggest decliners.

  • BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 40.0%.

  • Volatility is forecast to fall over the next month.

  • BIIB is above its 200-day moving average, providing a measure of support for long positions.

Low High Price as % of Range
$216.71 $338.96 61.6%
200 day 50 day 20 day 10 day
$250.08 $293.85 $295.30 $292.20
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
37.2% 37.6% 40.0% 37.6%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 10.9% in the next week.

  • 21.3% in the next month.

  • 84.4% in the next year.